Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.45 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.44 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | GABRP | O00591 | 2/20 | 0.41 |
| ▸ | GABRD | O14764 | 2/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25366448 | 1.00 | HCAR2 (0.45) | HCAR2MTNR1AMTNR1BGAACYP1A2 | |
| SCHEMBL11220370 | 0.86 | ALDH1A1 (0.50) | MTNR1BGAACYP1A2CYP2C9PKM | |
| SCHEMBL11220363 | 0.86 | ALDH1A1 (0.50) | MTNR1BGAACYP1A2CYP2C9PKM | |
| SCHEMBL9473085 | 0.86 | CA12 (0.43) | HCAR2GAACYP1A2CYP2C9PKM | |
| SCHEMBL9473069 | 0.86 | CA12 (0.43) | HCAR2GAACYP1A2CYP2C9PKM | |
| SCHEMBL29035373 | 0.84 | TSHR (0.44) | HCAR2MTNR1AMTNR1BGAACYP1A2 | |
| SCHEMBL4758988 | 0.84 | HCAR2 (0.44) | HCAR2MTNR1AMTNR1BGAACYP1A2 | |
| SCHEMBL11403860 | 0.80 | ALDH1A1 (0.51) | ALDH1A1KMT2AKDM4ELMNASMN1; SMN2 | |
| SCHEMBL11443666 | 0.80 | ALDH1A1 (0.40) | GAACYP1A2CYP2C9PKMCYP2C19 | |
| SCHEMBL11281633 | 0.80 | ALDH1A1 (0.51) | ALDH1A1KMT2AKDM4ELMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9182665-B2 | White curable composition for printed circuit board, cured coating film using the same, and printed circuit board | TAIYO INK MFG. CO., LTD. (JP) | 2015-11-10 | — | — | US | disclosed |
| US-20150093690-A1 | WHITE CURABLE COMPOSITION FOR PRINTED CIRCUIT BOARD, CURED COATING FILM USING THE SAME, AND PRINTED CIRCUIT BOARD | TAIYO INK MFG. CO., LTD. (JP) | 2015-04-02 | — | — | US | disclosed |
| US-20150090482-A1 | CURABLE COMPOSITION FOR PRINTED CIRCUIT BOARD, CURED COATING FILM USING THE SAME, AND PRINTED CIRCUIT BOARD | TAIYO INK MFG. CO., LTD. (JP) | 2015-04-02 | — | — | US | disclosed |
| US-20040171867-A1 | Reactive monomer composition modified by a small-amount of lactones, an acrylic polyol resin, a curable resin composition, and a coating composition | OKAZAKI AKIRA (JP) | 2004-09-02 | — | — | US | disclosed |
| US-6767987-B2 | CURABLE RESIN COMPOSITION COMPRISING ACRYLIC POLYOL RESIN INCLUDING HYDROXYALKYL(METH)ACRYLATE COMPOSITION HAVING SMALL AMOUNT OF POLYMERIZED LACTONE MONOMER, AND MELAMINE RESIN | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-07-27 | — | — | US | disclosed |
| US-20030149227-A1 | Lowly lactone-modified reactive monomer composition, acrylic polyol resins produced with the same, curable resin compositions and coating compositions | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-08-07 | — | — | US | disclosed |
| EP-1227113-A1 | LOWLY LACTONE-MODIFIED REACTIVE MONOMER COMPOSITION, ACRYLIC POLYOL RESINS PRODUCED WITH THE SAME, CURABLE RESIN COMPOSITIONS AND COATING COMPOSITIONS | DAICEL CHEMICAL INDUSTRIES, Ltd. (JP) | 2002-07-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171867-A1 | Reactive monomer composition modified by a small-amount of lactones, an acrylic polyol resin, a curable resin composition, and a coating composition | MSR1, FUT4, MRE11 | HCAR2 655/4885MTNR1A 125/4885MTNR1B 246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.